Since BET bromodomain proteins are readers of histone acetylation, we assayed JQ1, a selective inhibitor of BET with efficacy against a number of different cancers, but it did not induce Rgs16::GFP in cultured primary PDA cells (5% FBS). The gene discussed is RGS16; the disease is Patent ductus arteriosus.